| Antigen: | von Willebrand Factor (VWF) |
| Clone: | RFF-VIII:R/2 |
| Subclass | IgG1 k |
| Species Raised In: | Mouse |
| Immunogen: | Purified human Factor VIII-VWF complex |
| Cross Reactivity: | Baboon. |
| Applications: | ELISA, FACS, Frozen, Immunofluorescence, Immunoprecipitation, Neutralising, Paraffin embedded, Western |
| Growth Conditions: | RPMI + 10% FCS; non-adherent; subculture every 2-3 days; split 1:5 |
| Fusion Partner: | P3/NS/1/Ag4 |
| Synonyms: | F8VWF |
| Relevance: | The monoclonal antibody RFF-VIII:R/1 specifically binds to human factor VIII related antigen (VIII:RAg) in plasma and in vascular endothelial cells but has no reactivity with factor VIII procoagulant antigen (VIII:cAg). This antibody is a potent inhibitor of von Willebrand factor activity in that it can totally neutralise risocetin-induced aggregation of platelet rich plasma and inhibit platelet adhesion at high flow rates. RFF-VIII:R/1 can be used in a one-stage, fluid phase immunoradiometric assay that can detect VIII:RAg. This monoclonal antibody binds to human von Willebrand factor (VW) and inhibits its binding to platelets. Very similar in characteristics to RFF-VIII:R/2 |
| References: | Chand S et al. 1986. Thrombosis & Haemostasis. 55: 318-24. PMID: 2428124Read more |
© Cancer Research Technology 2012